Showing 101-110 of 1846 results for "".
Juvederm Approved for Lips, CoolMini Applicator Cleared
https://practicaldermatology.com/topics/psoriasis/juvederm-approved-for-lips-coolmini-applicator-cleared/18828/In this edition, a look at Allergan's Juvederm Voluma XC approval for lips an Zeltiq's CoolMini applicator for treatment of the sub mental area. Plus, there's new data for secukinumab in psoriatic arthritis (PSA) and Kathleen Sebelius has joined the Board of Directors of Dermira.Dermatologists Push Back on Wall Street Journal Characterization
https://practicaldermatology.com/issues/january-february-2025/dermatologists-push-back-on-wsj-characterization/32900/Four-day workweeks, double the salary of some colleagues and no emails at night—those were the reasons a Wall Street Journal article concluded that medical residency applications for dermatology slots are up 50% over the past 5 years. Practical Dermatology reached out to dermatologists to get theirNoah Worcester 2024: Dr. Jogi on Hair Loss
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-jogi-hair-loss/24590/Joel L. Cohen, MD, FAAD, interviews Reena Jogi, MD about her lecture on hair loss and platelet-rich plasma at the 2024 Noah Worcester Dermatological Society meeting.Dupixent, Juvéderm Vollure XC, Bavencio Approvals
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-dupixent-juv-derm-vollure-xc-bavencio-approvals/18698/The FDA has approved Regeneron's injectable Dupixent (dupilumab) to treat adults with moderate-to-severe eczema. It will be marketed by Regeneron and Sanofi Genzyme in the US. Allergan's Juvéderm Vollure XC has received FDA approval based on a pivotal clinical trial in which 59 percent of subjects sSCALE 2024: Listen as Dr. Joel Cohen Interviews Dr. James Q. Del Rosso on Innovative Therapies
https://practicaldermatology.com/programs/practical-dermatology/scale-2024-listen-dr-joel-cohen-interviews-dr-james-q-del-rosso-innovative-therapies/26413/James Q. Del Rosso, DO, joins Joel Cohen, MD, to discuss innovation in the world of acne and rosacea, atopic dermatitis, psoriasis, alopecia areata, hidradenitis suppurativa, vitiligo, and more at Music City SCALE."Where to Start: Opening and Running a Private Practice" Drs. Jackson and Hooper
https://practicaldermatology.com/youngmd-connect/ymdc-workshops/where-to-start-opening-and-running-a-private-practice-drs-jackson-and-hooper/24544/Explore the essentials of starting and running a private practice in this unique webinar with Drs. Deirdre Hooper and Sarah Jackson. They cover practice setup, marketing, patient acquisition, and operational management, sharing invaluable insights for professional and financial success. To access moJames Del Rosso, DO: Thoughts on the FDA Citizen's Petition for Acne Products with Benzoyl Peroxide (BPO)
https://practicaldermatology.com/topics/acne-rosacea/james-del-rosso-do-thoughts-fda-citizens-petition-acne-products-benzoyl-peroxide-bpo/24173/James Q. Del Rosso, DO, a dermatologist and president of The American Acne and Rosacea Society (AARS), weighs in on a recent report from Valisure which finds that benzene can form at elevated levels in products for acne that contain benzoyl peroxide (BPO). The interview was conducted by Neal Bhatia,Graduating from Dermatology Residency into the COVID-19 Job Market
https://practicaldermatology.com/youngmd-connect/resident-resource-center/graduating-from-dermatology-residency-into-the-covid-19-job-market/23437/Third-year dermatology residents are graduating into an uncertain job market. What does the future hold?Allergan Board Rejects Latest Valeant Bid; Topical Jublia Approved for Onychomycosis
https://practicaldermatology.com/series/dermwire-tv/dwtv-6-12/19122/Allergan's board rejects the latest merger proposal from Valeant and the FDA approves topical Jublia for onychomycosis. LEarn about these developments and hear from the AMA's new president in this edition of DermWireTV.In-Office Photos Are an Indispensable Benefit According to Joel Schlessinger MD
https://practicaldermatology.com/topics/practice-management/in-office-photos-are-an-indispensable-benefit-according-to-joel-schlessinger-md-/19221/One way dermatologists can chart the success of their patients is by taking photos before, after and during their treatments. For over 20 years, Joel Schlessinger MD has incorporated photos of his patients into his practice. In this video, he describes the benefits of this technique. Joel Schless